Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock

被引:184
作者
Tsai, MH
Peng, YS
Chen, YC
Liu, NJ
Ho, YP
Fang, JT
Lien, JM
Yang, C
Chen, PC
Wu, CS
机构
[1] Chang Gung Mem Hosp, Div Gastroenterol, Taipei, Taiwan
[2] Chang Gung Mem Hosp, Div Endocrinol, Chiayi, Taiwan
[3] Chang Gung Mem Hosp, Div Crit Care Nephrol, Taipei 10591, Taiwan
关键词
D O I
10.1002/hep.21101
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Patients with cirrhosis are susceptible to bacterial infection, which can result in circulatory dysfunction, renal failure, hepatic encephalopathy, and a decreased survival rate. Severe sepsis is frequently associated with adrenal insufficiency, which may lead to hemodynamic instabity and a poor prognosis. We evaluated adrenal function using short corticotropin stimulation test (SST) in 101 critically ill patients with cirrhosis and severe sepsis. Adrenal insufficiency occurred in 51.48% of patients. The patients with adrenal insufficiency had a higher hospital mortality rate when compared with those with normal adrenal function (80-76% vs. 36.7%, P < .001). The cumulative rates of survival at 90 days were 15.3% and 63.2% for the adrenal insufficiency and normal adrenal function groups, respectively (P < .0001). The hospital survivors had a higher cortisol response to corticotropin (16.2 +/- 8.0 vs. 8.5 +/- 5.9 mu g/dL, P < .001). The cortisol response to corticotropin was inversely correlated with various disease severity, Model for End-Stage Liver Disease, and Child-Pugh scores. Acute physiology, age, chronic health evaluation III score, and cortisol increment were independent factors to predict hospital mortality. Mean arterial pressure on the day of SST was lower in patients with adrenal insufficiency (60 +/- 14 vs. 74.5 +/- 13 mm Hg, P < .001), and a higher proportion of these patients required vasopressors (73% vs. 24.48%, P < .001). Mean arterial pressure, serum bilirubin, vasopressor dependency, and bacteremia were independent factors that predicted adrenal insufficiency. In conclusion, adrenal insufficiency is common in critically ill patients with cirrhosis and severe sepsis. It is related to functional liver reserve and disease severity and is associated with hemodynamic instability, renal dysfunction, and increased mortality.
引用
收藏
页码:673 / 681
页数:9
相关论文
共 49 条
[1]   Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement [J].
Albillos, A ;
de la Hera, A ;
González, M ;
Moya, JL ;
Calleja, JL ;
Monserrat, J ;
Ruiz-del-Arbol, L ;
Alvarez-Mon, M .
HEPATOLOGY, 2003, 37 (01) :208-217
[2]   A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin [J].
Annane, D ;
Sébille, V ;
Troché, G ;
Raphaël, JC ;
Gajdos, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (08) :1038-1045
[3]   Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J].
Annane, D ;
Sébille, V ;
Charpentier, C ;
Bollaert, PE ;
François, B ;
Korach, JM ;
Capellier, G ;
Cohen, Y ;
Azoulay, E ;
Troché, G ;
Chaumet-Riffaut, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :862-871
[4]   Corticosteroids in sepsis: From bench to bedside? [J].
Annane, D ;
Cavaillon, JM .
SHOCK, 2003, 20 (03) :197-207
[5]  
ANNANE D, 1998, BR J CLIN PHARM, V46, P591
[6]  
Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1002/hep.510230122
[7]   Hepatorenal syndrome [J].
Bataller, R ;
Ginès, P ;
Guevara, M ;
Arroyo, V .
SEMINARS IN LIVER DISEASE, 1997, 17 (03) :233-247
[8]   Effect of hydrocortisone on phenylephrine-mean arterial pressure dose-response relationship in septic shock [J].
Bellissant, E ;
Annane, D .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (03) :293-303
[9]   Baseline cortisol levels, cortisol response to corticotropin, and prognosis in late septic shock [J].
Bollaert, PE ;
Fieux, F ;
Charpentier, C ;
Lévy, B .
SHOCK, 2003, 19 (01) :13-15
[10]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655